Watson Files ANDA With FDA To Market Sevelamer Carbonate
Watson’s Sevelamer carbonate tablet is the generic version of Genzyme’s Renvela, a phosphate binder indicated for the control of serum phosphorus in patients with chronic kidney disease who
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.
RoundTable has committed to support Renaissance Pharma with the full resources of the firm including substantial investment capital. RoundTable said that Mr Frechette brings experience to Renaissance Pharma